Shailen Shah

A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.

David Price, Shailen Shah, Sanjay Bhatia et al. · PubMed · 2013 · 87 citations

Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis

William E. Berger, Frank C. Hampel, Jonathan A. Bernstein et al. · Annals of Allergy Asthma & Immunology · 2006 · 77 citations

Asthma, Cetirizine Oral Tablets, Allergy +9

Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis

Parthiv J. Mahadevia, Shailen Shah, Christopher Leibman et al. · Annals of Allergy Asthma & Immunology · 2004 · 60 citations

Asthma, Sensory Attributes, Allergy +7

Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis

William E. Berger, Shailen Shah, Phil Lieberman et al. · The Journal of Allergy and Clinical Immunology In Practice · 2014 · 58 citations

Asthma, Translational Medicine, Allergy +8

Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients

Shailen Shah, Laura L. Somerville, Bhash Parasuraman et al. · Journal of Allergy and Clinical Immunology · 2008 · 51 citations · Full text

Asthma, Fixed-dose Budesonide/formoterol, Pulmonary Care +9